In summary, the potential biomarker genes proposed for SLE diagnosis are closely related to PI3K pathway, and the use of PI3K inhibitors reversed the changes associated with ISG15, OAS1, OASL, and IFIT1 (72, 78, 79). The gene discussed is ISG15; the disease is systemic lupus erythematosus.